Maziar Arfaee

Amsterdam University Medical Centers, Institute for Atomic and Molecular Physics

Papers

Total Citations

H-Index

About

Maziar Arfaee is a pioneering researcher in the field of cardiovascular bioengineering, with a focused mission to revolutionize the treatment of end-stage heart failure through next-generation total artificial hearts (TAHs). His work addresses the critical shortage of donor hearts by developing soft robotic and hybrid cardiac devices that aim to overcome the severe biocompatibility, size, and energy limitations of current mechanical hearts. Arfaee’s major contributions include proposing a novel soft robotic total artificial hybrid heart, which combines soft robotic actuation with a biocompatible inner lining to reduce mortality and improve patient quality of life. He has also advanced compact TAH designs using soft robotic fluidic transmission systems, tackling the persistent challenges of device miniaturization and power efficiency. His research, published in high-impact venues, has garnered significant attention, with his 2022 paper on the quest for the first destination-therapy TAH accumulating 43 citations. Through his visionary work, Arfaee is charting a path toward a future where a soft robotic heart can match or surpass the performance of a donor heart, offering new hope to millions suffering from cardiovascular disease.